Mapmygenome
Mapmygenome: Business Model Canvas
The nine-block Business Model Canvas, filled in only where a public source states it — empty blocks mean we haven't found a citable fact yet, not that the answer is zero.
Value Propositions
Flagship preventive genomics test covering physiological traits, diet/fitness fit, and disease risk.
sourceGenetic test for cardiovascular and diabetes risk plus drug-metabolism insight.
sourceIndia-focused DNA ancestry test built on an Indian reference database.
sourceCustomer Segments
Genomepatri Juniors is an at-home genetic test aimed at parents assessing children's nutrition and lifestyle needs.
sourceConsumers seeking Indian-specific ethnicity and ancestral migration insights.
sourceCustomer Relationships
Channels
Tests ordered online with pan-India logistics for sample kits and digital delivery of reports.
sourceDNA health tests offered through Apollo Clinic centres across India.
sourceKey Activities
Key Resources
Key Partnerships
Clinical distribution partnership offering Mapmygenome's DNA health tests at Apollo Clinic centres.
sourceCAP-accredited Canadian microbiome sequencing lab acquired to add global microbiome/metagenomics capability.
sourceRevenue Streams
Personal genomics tests sold directly to consumers, priced by product/panel.
sourceCost Structure
FAQs on Mapmygenome
What is Mapmygenome's business model?
Mapmygenome's core value proposition centers on Genomepatri (personal genomics), Cardiomap (cardiac & diabetes risk), Oncomap (cancer risk), Genomepatri Heritage (ancestry).
How does Mapmygenome make money?
Mapmygenome's cited revenue streams include Direct-to-consumer test sales.